BOTHELL, WA and ATLANTA, GA–(Marketwired – Apr 24, 2017) – On April 20, 2017, Cocrystal Pharma, Inc. (OTCQB: COCP) (the “Company”) closed on proceeds of $3,000,000 in a private placement offering (the “Offering”) of 12,500,000 shares of the Company’s common stock at a purchase price of $0.24 per share. The purchasers included one of the members of the Company’s board of directors, Chairman Dr. Raymond F. Schinazi. In addition, OPKO Health, Inc. invested in the Offering, of which the Company’sRead more
- PotNetwork Holding Inc. Surpasses First Quarter Estimates with Revenues Exceeding More Than $1.8 Million
- GVCL Ventures, Inc. Approves Global Vision Cannabis Life as its Operating Name
- CD International Enterprises Enters a Wholesale Distribution Agreement Including Products for Relaxation and Flavored Hemp Oils
- Developments Happening in the Diverse Entertainment Industry
- Aldershot Resources Canada’s Newest Gold Discovery
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More
Stay up to date with the latest news and other alerts!
Technology shown to distinguish disease-causing potentially life-threatening Staphylococcus strains from Staphylococcus present due to environmental contamination, supporting more accurate diagnosis, better patient care and healthcare cost savings SALT LAKE CITY, April 06, 2017, GBSN, (GLOBE NEWSWIRE) — Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that a research article, “A Novel Approach to Eliminate Detection of Contaminating Staphylococcal Species Introduced During Clinical Trial,” was published in PLOS ONE, a peer-reviewed scientific journal. The full article can beRead more
COLUMBUS, Ohio and ROCHESTER, Mich., April 05, 2017, OPRX, (GLOBE NEWSWIRE) — SingleCare Services, LLC, the leading provider of prescription savings programs, has partnered with OptimizeRx Corp. (OTCQB:OPRX), the leading aggregator of sponsored services in the electronic health records (EHR) space. The exclusive partnership provides OptimizeRx clients the opportunity to connect their customers with the right drug, at the right time, at the right price, through SingleCare’s prescription savings program. The integration of SingleCare’s pharmacy offering with OptimizeRx’s platform willRead more
NEW YORK, March 30, 2017, TNXP, (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (“Tonix”) (Nasdaq:TNXP), a company that is developing innovative pharmaceutical products to address public health challenges, announced today the pricing of an underwritten public offering of 1,800,000 shares of its common stock at a public offering price of $4.45 per share. The gross proceeds to Tonix from this offering are expected to be $8,010,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Tonix. TonixRead more
Worldwide License for Mino-Lok™ is Now Complete CRANFORD, N.J., March 23, 2017, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has recently concluded negotiations to add South America to its worldwide license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (“MDACC”), andRead more
ORLANDO, Fla., March 17, 2017, IMUN, (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using Lodonal™, its proprietary formulation of lower-dose naltrexone, announced today that the Dominican Republic Ministry of Public Health has granted Immune’s request to export Lodonal to Kenya. Immune Therapeutics formulates and manufactures Lodonal in the Dominican Republic. Local laws require a Certificate of Pharmaceutical Product (“COPP”) to export Lodonal to Kenya. “The granting of our exportRead more